Rebound Syndrome in Patients With Multiple Sclerosis After Cessation of Fingolimod Treatment

The appropriate sequencing of agents with strong immune system effects has become increasingly important. Transitions require careful balance between safety and protection against relapse. The cases presented herein highlight that rebound events after ceasing fingolimod treatment may happen even wit...

Full description

Bibliographic Details

Published in:	JAMA neurology Vol. 73; no. 7; pp. 790 - 794
Main Authors:	Hatcher, Stacy Ellen, Waubant, Emmanuelle, Nourbakhsh, Bardia, Crabtree-Hartman, Elizabeth, Graves, Jennifer S
Format:	Journal Article
Language:	English
Published:	United States 01.07.2016
Subjects:	Adult Female Fingolimod Hydrochloride - adverse effects Humans Immunosuppressive Agents - adverse effects Longitudinal Studies Magnetic Resonance Imaging Middle Aged Multiple Sclerosis - diagnostic imaging Multiple Sclerosis - drug therapy Multiple Sclerosis, Relapsing-Remitting - chemically induced Multiple Sclerosis, Relapsing-Remitting - diagnostic imaging PubMed - statistics & numerical data Recurrence
ISSN:	2168-6157
Online Access:	Get more information
Tags:	Add Tag No Tags, Be the first to tag this record!